Cargando…

Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial

During COVID-19 pandemic, clinicians have had to deal with an ever-increasing number of cases of olfactory disturbances after SARS-CoV-2 infections and in some people this problem persisted for long time after negativization from virus. This a prospective randomized controlled trial aims at evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Stadio, Arianna, Cantone, Elena, De Luca, Pietro, Di Nola, Claudio, Massimilla, Eva A., Motta, Giovanni, La Mantia, Ignazio, Motta, Gaetano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135838/ https://www.ncbi.nlm.nih.gov/pubmed/37189728 http://dx.doi.org/10.3390/biomedicines11041109

Ejemplares similares

Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial
por: Di Stadio, Arianna, et al.
Publicado: (2022)

Post-viral olfactory loss and parosmia
por: Liu, Zhen Yu, et al.
Publicado: (2023)

Entorhinal Cortex and Persistent Olfactory Loss in COVID-19 Patients: A Neuroanatomical Hypothesis. Comment on Fiorentino et al. Correlations between Persistent Olfactory and Semantic Memory Disorders after SARS-CoV-2 Infection. Brain Sci. 2022, 12, 714
por: De Luca, Pietro, et al.
Publicado: (2022)

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation
por: Roncati, Luca, et al.
Publicado: (2021)

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
por: Noce, Annalisa, et al.
Publicado: (2021)

Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
por: Albanese, Maria, et al.
Publicado: (2022)

Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial
por: Di Stadio, Arianna, et al.
Publicado: (2023)

QoL Following Dacryocystorhinostomy: Linguistic Adaptation of Italian Version of GBI
por: Cantone, Elena, et al.
Publicado: (2023)

Minimal Margin Surgery and Intraoperative Neuromonitoring in Benign Parotid Gland Tumors: Retrospective Clinical Study
por: Massimilla, Eva Aurora, et al.
Publicado: (2022)

Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
por: Cantone, Elena, et al.
Publicado: (2022)

Clinical Markers of Need for Surgery in Orbital Complication of Acute Rhinosinusitis in Children: Overview and Systematic Review
por: Cantone, Elena, et al.
Publicado: (2022)

Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia
por: Sekine, Rumi, et al.
Publicado: (2022)

A parosmia severity index based on word-classification predicts olfactory abilities and impairment
por: Hörberg, Thomas, et al.
Publicado: (2023)

Endotyping of Cholesteatoma: Which Molecular Biomarkers? A Systematic Review
por: Cantone, Elena, et al.
Publicado: (2022)

Sedation with Intranasal Dexmedetomidine in the Pediatric Population for Auditory Brainstem Response Testing: Review of the Existing Literature
por: Marra, Pasquale, et al.
Publicado: (2022)

A Supplement with Ribes Nigrum, Boswellia Serrata, Bromelain and Vitamin D to Stop Local Inflammation in Chronic Sinusitis: A Case-Control Study
por: De Luca, Pietro, et al.
Publicado: (2023)

Multimodality Imaging With PET/CT and MRI Reveals Hypometabolism in Tertiary Olfactory Cortex in Parosmia of COVID-19
por: Yousefi-Koma, Abbas, et al.
Publicado: (2021)

Parosmia and Phantosmia: Managing Quality Disorders
por: Altundag, Aytug
Publicado: (2023)

Parosmia and Neurological Disorders: A Neglected Association
por: Ciurleo, Rosella, et al.
Publicado: (2020)

Orthonasal and retronasal odor identification in patients with parosmia
por: Li, Shubin, et al.
Publicado: (2023)

Single-Center-Single-Blinded Clinical Trial to Evaluate the Efficacy of a Nutraceutical Containing Boswellia Serrata, Bromelain, Zinc, Magnesium, Honey, Tyndallized Lactobacillus Acidophilus and Casei to Fight Upper Respiratory Tract Infection and Otitis Media
por: Della Volpe, Antonio, et al.
Publicado: (2022)

Parosmia assessment with structured questions and its functional impact in patients with long‐term COVID‐19–related olfactory dysfunction
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2022)

Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?
por: Di Stadio, Arianna, et al.
Publicado: (2023)

The effect of female hormone in otosclerosis. A comparative study and speculation about their effect on the ossicular chain based on the clinical results
por: Ricci, Giampietro, et al.
Publicado: (2022)

Intravascular Papillary Endothelial Hyperplasia (Masson’s Tumor) of the Supraclavicular Region: Management of a Rare Case
por: Massimilla, Eva Aurora, et al.
Publicado: (2022)

Transoral Approach to Parapharyngeal Space Tumours: Preliminary Reports from a Single-Centre Retrospective Analysis
por: Motta, Giovanni, et al.
Publicado: (2023)

Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2018)

Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells
por: Barbierato, Massimo, et al.
Publicado: (2015)

Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: D’Amico, Ramona, et al.
Publicado: (2021)

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
por: Caltagirone, Carlo, et al.
Publicado: (2015)

The Effects of Olfactory Loss and Parosmia on Food and Cooking Habits, Sensory Awareness, and Quality of Life—A Possible Avenue for Regaining Enjoyment of Food
por: Fjaeldstad, Alexander Wieck, et al.
Publicado: (2022)

Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections
por: Menzel, Susanne, et al.
Publicado: (2022)

Effects of Ultramicronized N-Palmitoylethanolamine Supplementation on Tramadol and Oxycodone Analgesia and Tolerance Prevention
por: Micheli, Laura, et al.
Publicado: (2022)

COVID-19-Associated Parosmia and Dysgeusia: A Case Series
por: Ivona, Javier A, et al.
Publicado: (2021)

Post-COVID-19 Vaccine Parosmia: A Case Report
por: Zamzami, Osama S, et al.
Publicado: (2021)

Persistent Parosmia Caused By COVID-19 Infection: An Emerging Symptom
por: Khalifah, Wael, et al.
Publicado: (2021)

Insights into the molecular triggers of parosmia based on gas chromatography olfactometry
por: Parker, Jane K., et al.
Publicado: (2022)

Parosmia and altered taste in patients recovering from Covid 19
por: Kelly, Christine E.
Publicado: (2023)

Extracapsular Tonsillectomy versus Intracapsular Tonsillotomy in Paediatric Patients with OSAS
por: Mesolella, Massimo, et al.
Publicado: (2023)

Nasal Microbiota and Neuroinflammation: Relationship between Nasal Flora and Multiple Sclerosis Onset/Progression
por: Gioacchini, Federico Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btr5hudpmj0jo4ohm7j8bftar3